CSIMarket
 


Omeros Corp  (OMER)
Other Ticker:  
 

Cumulative Omeros's Leverage Ratio for Trailing Twelve Months Period

OMER's Leverage Ratio for Trailing Twelve Months Period and Total Liabilities, Equity growth


Select the Comparisons : Select the Ratio:

OMER Leverage Ratio for Trailing Twelve Months Period

(Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
(Sep 30 2022)
III. Quarter
Y / Y Equity Growth - - - 260.32 % -
Y / Y Total Liabilities Growth 4.14 % -3.51 % -3.68 % -9.66 % -8.23 %
Leverage Ratio for Trailing Twelve Months Period 9.86 12.52 23.54 840.02 -
Total Ranking # # # # #
Seq. Equity Growth - -62.67 % -35.89 % - -
Seq. Total Liabilities Growth 1.08 % 1.29 % 0.87 % 0.83 % -6.35 %


Leverage Ratio for Trailing Twelve Months Period Comment for 12 Months ending at Sep 30 2023
On the trailing twelve months basis In the III. Quarter company had stockholder deficit.
Leverage Ratio for Trailing Twelve Months Period is the average cumulative value over the last four quarters.

Among companies in Major Pharmaceutical Preparations industry Omeros Corp achieved the lowest Leverage Ratio for Trailing Twelve Months Period. While total ranking remained unchanged compare to previous quarter at no. .

What is Leverage Ratio?
Who are OMER's Customers?
Leverage Ratio for Trailing Twelve Months Period Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #


Leverage Ratio for Trailing Twelve Months Period Statistics
High Average Low
0 0 0
 




Companies with similar average Leverage Ratio for Trailing Twelve Months Period for 12 months ending Sep 30 2023, within Major Pharmaceutical Preparations Industry Leverage Ratio for Trailing Twelve Months Period
Morphosys Ag  20.42 
Amneal Pharmaceuticals Inc   19.81 
Jaguar Health inc   19.64 
Aravive Inc   17.88 
Innovation1 Biotech Inc   17.82 
Clearside Biomedical Inc   14.81 
Clearmind Medicine Inc   14.75 
Novan Inc   14.27 
Seres Therapeutics Inc   14.09 
Reata Pharmaceuticals Inc   11.79 
Earth Science Tech Inc   11.56 
Xeris Biopharma Holdings Inc   9.85 
Gossamer Bio Inc   9.21 
Akari Therapeutics Plc  9.01 
Effector Therapeutics Inc   7.02 
Fortress Biotech Inc   6.48 
Mallinckrodt Plc  6.42 
Aslan Pharmaceuticals Limited  6.31 
Puma Biotechnology Inc   6.31 
Nabriva Therapeutics Plc  6.19 
Abbvie inc   6.18 
Zyversa Therapeutics Inc   6.00 
Soligenix inc   5.64 
Kala Bio inc   5.42 
Ionis Pharmaceuticals Inc  5.16 
Collegium Pharmaceutical Inc   5.14 
Harrow Inc   5.09 
Therapeuticsmd Inc   5.03 
Nrx Pharmaceuticals Inc   4.99 
Cingulate Inc   4.98 




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com